UMIN-CTR History

UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials


Unique ID issued by UMIN UMIN000015098
Receipt No. R000017566
Scientific Title Phase II study of S-1+CPT-11+Bevacizumab as second-line therapy in metastatic colorectal cancer which has prior therapy of S-1+L-OHP+Bevacizumab
Date of disclosure of the study information 2014/09/09
Last modified on 2019/10/07 14:49:57

No. Disposal Last modified on Item of update
1 Insert 2014/09/09 16:13:52
2 Update 2014/09/09 16:30:53 Date of disclosure of the study information
3 Update 2019/09/30 17:53:56 UMIN ID1
4 Update 2019/10/07 14:49:57 Recruitment status
Date of IRB
Last follow-up date

Contact us.